pre-update Archives

Blog

Quantitative Systems Pharmacology (QSP) Modeling for Immunotherapy-induced Cytokine Release Syndrome

Cytokine Release Syndrome Cytokine release syndrome (CRS) is an inflammatory immune reaction that clinically manifests…

CertaraAugust 20, 2024

On-Demand Webinar

Navigating New Terrain: Joint Advice on FDA/EMA Compliance – Aligning with Evolving EU Regulations

Presentation Materials

CertaraAugust 20, 2024

On-Demand Webinar

Navigating New Terrain: The Impact of Evolving EU Regulations on Regulatory Affairs

Presentation Materials Don't miss Part 2 in the series Joint Advice on FDA/EMA Compliance…

CertaraAugust 20, 2024

On-Demand Webinar

Using Quantitative Systems Pharmacology (QSP) Modeling for Oncology Dose Optimization

The FDA’s Project Optimus initiative aims to reform dose optimization and selection for oncology therapies…

CertaraAugust 19, 2024

Blog

Automation in clinical trials: Why it’s essential for success

Many companies in the life sciences industry are slow to adopt new technologies. This is…

CertaraAugust 19, 2024

Blog

Subject Exposure in Aggregate Safety Reports & Common Issues

All new and existing drugs should be safe, effective, and efficacious for the treated populations.…

CertaraAugust 16, 2024

Press Release

Certara Launches Phoenix™ Version 8.5 Drug Development Software

RADNOR, PA – August 15, 2024 - Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraAugust 15, 2024

Announcement

Certara Research Reveals IRA’s Impact on Biosimilar Uptake

RADNOR, PA - August 15, 2024 -- Certara, Inc., a global leader in model-informed drug…

CertaraAugust 15, 2024

On-Demand Webinar

Mastering Value Storytelling in Healthcare: Leveraging Digital Tools to Meet Stakeholders’ Expectations

Everyone loves a good story. Stories are more likely to move and engage people than…

CertaraAugust 14, 2024

White Paper

Evaluating the IRA’s Impact on Medicare Part B Biosimilar Reimbursement

White paper exploring the IRA’s small but measurable impact in several key areas

CertaraAugust 13, 2024

pre-update

Quantitative Systems Pharmacology (QSP) Modeling for Immunotherapy-induced Cytokine Release Syndrome

Navigating New Terrain: Joint Advice on FDA/EMA Compliance – Aligning with Evolving EU Regulations

Navigating New Terrain: The Impact of Evolving EU Regulations on Regulatory Affairs

Using Quantitative Systems Pharmacology (QSP) Modeling for Oncology Dose Optimization

Automation in clinical trials: Why it’s essential for success

Subject Exposure in Aggregate Safety Reports & Common Issues

Certara Launches Phoenix™ Version 8.5 Drug Development Software

Certara Research Reveals IRA’s Impact on Biosimilar Uptake

Mastering Value Storytelling in Healthcare: Leveraging Digital Tools to Meet Stakeholders’ Expectations

Evaluating the IRA’s Impact on Medicare Part B Biosimilar Reimbursement

Newsletter sign up

Quick links

Solutions

Contact